711 related articles for article (PubMed ID: 34502047)
1. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases.
Hyun CK
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502047
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
5. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
7. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
Michielan A; D'Incà R
Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
[TBL] [Abstract][Full Text] [Related]
10. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk between gut bacteria and host immunity in intestinal inflammation.
Yang Q; Wang Y; Jia A; Wang Y; Bi Y; Liu G
J Cell Physiol; 2021 Apr; 236(4):2239-2254. PubMed ID: 32853458
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
Guo XY; Liu XJ; Hao JY
J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
[TBL] [Abstract][Full Text] [Related]
14. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
15. The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor Receptor.
Pernomian L; Duarte-Silva M; de Barros Cardoso CR
Clin Rev Allergy Immunol; 2020 Dec; 59(3):382-390. PubMed ID: 32279195
[TBL] [Abstract][Full Text] [Related]
16. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
Sittipo P; Shim JW; Lee YK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
[TBL] [Abstract][Full Text] [Related]
17. Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease.
Li J; Zhou H; Fu X; Zhang M; Sun F; Fan H
Immunol Lett; 2021 Apr; 232():39-44. PubMed ID: 33582183
[TBL] [Abstract][Full Text] [Related]
18. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
Kudelka MR; Stowell SR; Cummings RD; Neish AS
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):597-617. PubMed ID: 32710014
[TBL] [Abstract][Full Text] [Related]
19. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Deleu S; Machiels K; Raes J; Verbeke K; Vermeire S
EBioMedicine; 2021 Apr; 66():103293. PubMed ID: 33813134
[TBL] [Abstract][Full Text] [Related]
20. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
Hu Y; Chen Z; Xu C; Kan S; Chen D
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
